These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 3667008

  • 1. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G, Cresci F, Lo Sapio P, Panuccio P.
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [Abstract] [Full Text] [Related]

  • 2. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C, Grassi V, Verdecchia P, Cornelli U, Sorbini CA.
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [Abstract] [Full Text] [Related]

  • 3. Effect of theophylline in chronic obstructive lung disease.
    Umut S, Gemicioğlu B, Yildirim N, Barlas A, Ozüner Z.
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [Abstract] [Full Text] [Related]

  • 4. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA, Wiggins J, Ayres JG, Stableforth DE.
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [Abstract] [Full Text] [Related]

  • 5. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J, Mirtallo JM, Altman M.
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract] [Full Text] [Related]

  • 6. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R.
    Wien Med Wochenschr; 1993 May; 143(2):37-42. PubMed ID: 8488685
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G.
    Wien Med Wochenschr; 1984 Apr 15; 134(7):163-9. PubMed ID: 6741156
    [Abstract] [Full Text] [Related]

  • 8. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D, Cuglituri G, Rossini L, Bonfardeci G.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun 15; 27(6):273-5. PubMed ID: 2737795
    [Abstract] [Full Text] [Related]

  • 9. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
    Gandola L, Aiolfi S, Soccini F, Patrini G, Capellini G, Scartabellati A, Ghio L, Mauri F.
    Clin Ter; 1989 Dec 15; 131(5):293-7. PubMed ID: 2532583
    [Abstract] [Full Text] [Related]

  • 10. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC, Gotz VP, Robinson JD, Russell WL, Ryerson GG.
    Clin Pharm; 1983 Dec 15; 2(4):347-52. PubMed ID: 6883961
    [Abstract] [Full Text] [Related]

  • 11. Long-term therapy with sustained-release theophylline.
    Myhre KI, Arnulf V, Walstad RA.
    Pharmatherapeutica; 1985 Dec 15; 4(2):92-7. PubMed ID: 3903782
    [Abstract] [Full Text] [Related]

  • 12. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B, Sehrt I, Iwainsky H.
    Z Erkr Atmungsorgane; 1984 Dec 15; 162(1):3-10. PubMed ID: 6719957
    [Abstract] [Full Text] [Related]

  • 13. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec 15; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 14. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM, Terra Filho M, Cukier A, Santos SR, Verrastro C, Teixeira LR, Vargas FS.
    Rev Hosp Clin Fac Med Sao Paulo; 1991 Dec 15; 46(4):166-9. PubMed ID: 1843713
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V, Nicora M, Beretta A.
    Int J Clin Pharmacol Res; 1987 Dec 15; 7(5):337-44. PubMed ID: 3667006
    [Abstract] [Full Text] [Related]

  • 16. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y, Liu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct 15; 20(5):294-8. PubMed ID: 10374456
    [Abstract] [Full Text] [Related]

  • 17. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
    Dal Negro R, Turco P, Pomari C, Monici-Preti P.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul 15; 25(7):401-5. PubMed ID: 3305382
    [Abstract] [Full Text] [Related]

  • 18. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F, De Maria P, Ronchi E, Galimberti M.
    Int J Clin Pharmacol Ther; 1997 Mar 15; 35(3):107-11. PubMed ID: 9088999
    [Abstract] [Full Text] [Related]

  • 19. [Prescription of Theostat 300 as a single evening dose].
    Germouty J, Bida C, Moreau L.
    Rev Pneumol Clin; 1987 Mar 15; 43(5):262-5. PubMed ID: 3324266
    [Abstract] [Full Text] [Related]

  • 20. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S, Laver J, Benson L, Cotariu D, Neli P, Saidman JL, Viure E.
    Isr J Med Sci; 1982 Feb 15; 18(2):255-8. PubMed ID: 7068356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.